These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin. Bronowicki JP; Ouzan D; Asselah T; Desmorat H; Zarski JP; Foucher J; Bourlière M; Renou C; Tran A; Melin P; Hézode C; Chevalier M; Bouvier-Alias M; Chevaliez S; Montestruc F; Lonjon-Domanec I; Pawlotsky JM Gastroenterology; 2006 Oct; 131(4):1040-8. PubMed ID: 17030174 [TBL] [Abstract][Full Text] [Related]
14. [The study of optimal treatment in patients with refractory chronic hepatitis C]. Chen XY; Zhang YH Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):488-9. PubMed ID: 19912679 [No Abstract] [Full Text] [Related]
15. [Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases]. Lopukhova NL Eksp Klin Gastroenterol; 2007; (4):146-52. PubMed ID: 18409502 [No Abstract] [Full Text] [Related]
16. Viral kinetics in the treatment of chronic hepatitis C. Layden-Almer JE; Cotler SJ; Layden TJ J Viral Hepat; 2006 Aug; 13(8):499-504. PubMed ID: 16901279 [TBL] [Abstract][Full Text] [Related]
17. Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses. Inoue Y; Hiramatsu N; Oze T; Yakushijin T; Mochizuki K; Hagiwara H; Oshita M; Mita E; Fukui H; Inada M; Tamura S; Yoshihara H; Hayashi E; Inoue A; Imai Y; Kato M; Miyagi T; Hohsui A; Ishida H; Kiso S; Kanto T; Kasahara A; Takehara T; Hayashi N J Viral Hepat; 2010 May; 17(5):336-44. PubMed ID: 19678893 [TBL] [Abstract][Full Text] [Related]
18. [Early virologic response in retherapy with pegylated interferon alpha-2B plus ribavirin in children with chronic hepatitis C]. Pawłowska M; Palewicz E; Halota W Przegl Epidemiol; 2006; 60(1):71-7. PubMed ID: 16758742 [TBL] [Abstract][Full Text] [Related]
19. [Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection]. Kang MJ; Jung EU; Park SW; Choi P; Kim JH; Park SJ; Park ET; Lee YJ; Lee SH; Seol SY Korean J Hepatol; 2008 Sep; 14(3):318-30. PubMed ID: 18815455 [TBL] [Abstract][Full Text] [Related]
20. An open pilot study exploring the efficacy of fluvastatin, pegylated interferon and ribavirin in patients with hepatitis C virus genotype 1b in high viral loads. Sezaki H; Suzuki F; Akuta N; Yatsuji H; Hosaka T; Kobayashi M; Suzuki Y; Arase Y; Ikeda K; Miyakawa Y; Kumada H Intervirology; 2009; 52(1):43-8. PubMed ID: 19372703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]